Dr. Reddy's launches novel recombinant Hepatitis E vaccine ‘Hevaxin’ in India
It is currently the only vaccine authorized by the Drug Controller General of India (DCGI) for active immunization against HEV in adults aged 18 to 65
It is currently the only vaccine authorized by the Drug Controller General of India (DCGI) for active immunization against HEV in adults aged 18 to 65
The work will leverage ProBioGen’s CHO.RiGHT expression platform, powered by its proprietary DirectedLuck transposase technology, alongside PsiBot smart automation
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Rajdeep is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostic sector
The approval introduces a needle-free alternative to injectable GLP-1 therapies
The state-of-the-art laboratory opens at the Corewell Health Southfield Center in early 2027
Pembrolizumab has shown meaningful benefit only when combined with chemotherapy
The filing clears the regulatory path for potential first-in-human trials and marks a key advance in the company’s chronic inflammatory disease pipeline
Dr. Chand held several leadership positions within AstraZeneca and the broader biopharmaceutical industry
Before this appointment, he served as the Secretary in the Department of Land Resources, Ministry of Rural Development
Subscribe To Our Newsletter & Stay Updated